The store will not work correctly when cookies are disabled.
5-(2,3-Dichlorophenyl)-[1,2,4]triazolo[1,5-a]pyridine-2,8-diamine
ID: ALA4475123
PubChem CID: 155537615
Max Phase: Preclinical
Molecular Formula: C12H9Cl2N5
Molecular Weight: 294.15
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1nc2c(N)ccc(-c3cccc(Cl)c3Cl)n2n1
Standard InChI: InChI=1S/C12H9Cl2N5/c13-7-3-1-2-6(10(7)14)9-5-4-8(15)11-17-12(16)18-19(9)11/h1-5H,15H2,(H2,16,18)
Standard InChI Key: GXNVBZVGEQCMRG-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
25.7908 -12.6609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5004 -12.2514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4976 -11.4288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7890 -11.0235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0827 -12.2519 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0794 -11.4309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2975 -11.1803 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.8175 -11.8465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3029 -12.5088 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9969 -11.8410 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.7925 -13.4759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0830 -13.8837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0825 -14.7002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7906 -15.1097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5008 -14.6969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4978 -13.8818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2045 -13.4715 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
27.2098 -15.1032 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
25.7883 -10.2063 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
8 10 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
1 11 1 0
16 17 1 0
15 18 1 0
4 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.15 | Molecular Weight (Monoisotopic): 293.0235 | AlogP: 2.87 | #Rotatable Bonds: 1 |
Polar Surface Area: 82.23 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.00 | CX LogP: 2.96 | CX LogD: 2.96 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.72 | Np Likeness Score: -1.35 |
References
1. Farand J, Kropf JE, Blomgren P, Xu J, Schmitt AC, Newby ZE, Wang T, Murakami E, Barauskas O, Sudhamsu J, Feng JY, Niedziela-Majka A, Schultz BE, Schwartz K, Viatchenko-Karpinski S, Kornyeyev D, Kashishian A, Fan P, Chen X, Lansdon EB, Ports MO, Currie KS, Watkins WJ, Notte GT.. (2020) Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)Validation., 11 (3): [PMID:32184970] [10.1021/acsmedchemlett.9b00420] |